Michael Howell
Chief Tech/Sci/R&D Officer bij ZURA BIO LIMITED
Vermogen: 314 522 $ op 31-03-2024
Profiel
Dr. Michael D.
Howell is a Chief Scientific Officer at Zura Bio Ltd.
Dr. Howell was previously employed as a Chief Scientific Officer by DermTech, Inc. and a Head-Translational Research by Incyte Corp.
He received his undergraduate degree from the University of Messiah and a doctorate degree from West Virginia University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ZURA BIO LIMITED CLASS A
0.28% | 22-04-2024 | 122 382 ( 0.28% ) | 314 522 $ | 31-03-2024 |
Actieve functies van Michael Howell
| Bedrijven | Functie | Begin |
|---|---|---|
| ZURA BIO LIMITED | Chief Tech/Sci/R&D Officer | 14-04-2023 |
Eerdere bekende functies van Michael Howell
| Bedrijven | Functie | Einde |
|---|---|---|
| DERMTECH, INC. | Chief Tech/Sci/R&D Officer | 01-11-2022 |
| INCYTE CORPORATION | Corporate Officer/Principal | - |
Opleiding van Michael Howell
| University of Messiah | Undergraduate Degree |
| West Virginia University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| DERMTECH, INC. | Health Technology |
| ZURA BIO LIMITED | Health Technology |
